Skip to main content
The Medscape Journal of Medicine logoLink to The Medscape Journal of Medicine
letter
. 2008 Apr 10;10(4):84.

A Reader Responds to “Fat Reduction by Topical Waist Applications May Actually Work”

Ayaz Virji 1
PMCID: PMC2390692  PMID: 18504481

To the Editor,

Aminophylline is a methylxanthine inhibitor and has a beta- mimetic effect on adipocytes. B3 receptors on adipocytes are lipolytic when stimulated. So, the mechanism of action makes sense. Aminophylline is a common compound found in many mesotherapy formulas for spot fat reduction. A similar article was published by Greenway and Bray in the 1980s showing similar results on women's thighs.[1] Be cautious, though: There is no panacea for obesity. The cream, like the aminophylline found in mesotherapy lipodissolve, will only work on subcutaneous fat, not the dangerous visceral fat responsible for escalating risk for CAD [coronary artery disease], diabetes, and cancer. Aminophylline may be useful for body contouring for people with a BMI [body mass index] of 30 or less, but in no way should be considered a weight loss treatment.[2]

Footnotes

Reader Comments on: Fat Reduction by Topical Waist Applications May Actually Work See reader comments on this article and provide your own.

Readers are encouraged to respond to George Lundberg, MD, Editor in Chief of The Medscape Journal of Medicine, for the editor's eyes only or for possible publication as an actual Letter in the Medscape Journal via email: glundberg@medscape.net

References


Articles from The Medscape Journal of Medicine are provided here courtesy of WebMD/Medscape Health Network

RESOURCES